HPV infection with 'high-risk'genotypes is associated with ano-genital and oropharyngeal
cancers. Two currently licensed prophylactic HPV vaccines designed to prevent disease …

Human papillomavirus (HPV) types 16 and 18 cause 70% of cervical cancer cases globally.
The nonavalent HPV vaccine (9vHPV) was licensed in 2014 and protects against the next …

Human Papillomavirus (HPV) infection causes cervical cancer, a significant portion of anal,
vulvar, vaginal, and oropharyngeal cancers, genital warts, and recurrent respiratory …

Human papillomavirus (HPV) is the most common sexually transmitted infectious agent; its
14 oncogenic types are causally associated with 5–10% of all cancers. The major structural …

Human papillomavirus (HPV) is the necessary cause of cervical cancer, the fourth most
common cancer and cause of cancer-related death in females worldwide. HPV also causes …

Human papillomavirus (HPV) is the causative agent of nearly all cervical cancer cases as
well as a substantial proportion of anal, vulvar, vaginal, penile and oropharyngeal cancers …

Background Cervical cancer remains a major cause of cancer death in women worldwide.
Moreover, human papillomavirus (HPV)-related disease of the urogenital tract (including …

BACKGROUND: Human papillomaviruses (HPVs) play an obligatory role in cervical cancer
devel-opment. Thus, immunization of women using a prophylactic vaccine against the most …

New prophylactic HPV vaccines have the power to prevent many HPV infections, thus
reducing the burden of HPV-associated diseases. Two vaccines composed of HPV L1 …

HPV‐related diseases affect anogenital and oropharyngeal regions, heavily affecting the
psychosexual dimension of both male and female individuals. HPV vaccination programs …